101
Participants
Start Date
August 21, 2020
Primary Completion Date
February 28, 2024
Study Completion Date
May 29, 2024
Restylane-L®
Restylane-L® for the indication for mid-to-deep dermal implantation for moderate to severe facial wrinkles and folds, such as nasolabial folds.
Restylane-L® Lyft
Restylane-L® Lyft is for the indication of implantation into the deep dermis to superficial subcutis for the correction of moderate to severe facial folds and wrinkles, such as nasolabial folds and malars (cheek/cheek bone area).
Restylane Silk®
Restylane Silk® is for the indication for submucosal implantation for lip augmentation and dermal implantation for correction of perioral rhytids in patients over the age of 21.
University of Pennsylvania Health System, Philadelphia
Collaborators (1)
Galderma R&D
INDUSTRY
University of Pennsylvania
OTHER